...
首页> 外文期刊>BMC Cancer >Modeling to capture bystander-killing effect by released payload in target positive tumor cells
【24h】

Modeling to capture bystander-killing effect by released payload in target positive tumor cells

机译:模拟靶阳性肿瘤细胞中释放有效载荷捕获旁观者杀伤效果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Antibody-drug conjugates (ADCs) are intended to bind to specific positive target antigens and eradicate only tumor cells from an intracellular released payload through the lysosomal protease. Payloads, such as MMAE, have the capacity to kill adjacent antigen-negative (Ag-) tumor cells, which is called the bystander-killing effect, as well as directly kill antigen-positive (Ag+) tumor cells. We propose that a dose-response curve should be independently considered to account for target antigen-positive/negative tumor cells. A model was developed to account for the payload in Ag+/Ag- cells and the associated parameters were applied. A tumor growth inhibition (TGI) effect was explored based on an ordinary differential equation (ODE) after substituting the payload concentration in Ag+/Ag- cells into an Emax model, which accounts for the dose-response curve. To observe the bystander-killing effects based on the amount of Ag+/Ag- cells, the Emax model is used independently. TGI models based on ODE are unsuitable for describing the initial delay through a tumor-drug interaction. This was solved using an age-structured model based on the stochastic process. β∈(0,1] is a fraction parameter that determines the proportion of cells that consist of Ag+/Ag- cells. The payload concentration decreases when the ratio of efflux to influx increases. The bystander-killing effect differs with varying amounts of Ag+ cells. The larger β is, the less bystander-killing effect. The decrease of the bystander-killing effect becomes stronger as Ag+ cells become larger than the Ag- cells. Overall, the ratio of efflux to influx, the amount of released payload, and the proportion of Ag+ cells determine the efficacy of the ADC. The tumor inhibition delay through a payload-tumor interaction, which goes through several stages, may be solved using an age-structured model. The bystander-killing effect, one of the most important topics of ADCs, has been explored in several studies without the use of modeling. We propose that the bystander-killing effect can be captured through a mathematical model when considering the Ag+ and Ag- cells. In addition, the TGI model based on the age-structure can capture the initial delay through a drug interaction as well as the bystander-killing effect.
机译:抗体 - 药物缀合物(ADC)旨在与特异性阳性靶抗原结合,并仅通过溶酶体蛋白酶从细胞内释放有效载荷根除肿瘤细胞。诸如MMAE的有效载荷具有杀死相邻抗原阴性(Ag-)肿瘤细胞的能力,该肿瘤细胞称为旁观者杀伤作用,以及直接杀死抗原阳性(Ag +)肿瘤细胞。我们提出了一种剂量 - 反应曲线应该被独立地被认为是靶向抗原阳性/阴性肿瘤细胞。开发了一种模型,以解释AG + / AG-细胞中的有效载荷,并应用相关参数。基于常微分方程(ode)在代替Ag + / Ag-cell中的常规差分方程(ode)中探索肿瘤生长抑制(TGI)效应,以估计剂量响应曲线来计算。要根据Ag + / Ag-Cell的量观察旁观者杀伤效果,EMAX模型独立使用。基于ODE的TGI模型不适合通过肿瘤 - 药物相互作用描述初始延迟。这是使用基于随机过程的年龄结构化模型来解决的。 β-(0,1]是确定Ag + / Ag-cell的细胞比例的级分数。当流出与流入的比率增加时,有效载荷浓度会降低。旁观者杀伤效果不同于Ag +的不同量细胞。较大的β是较小的旁观者杀伤效果。旁边杀伤效果的降低变得越强,因为Ag +细胞变得大于Ag-细胞。总体而言,释放释放量的流出比例,释放有效载荷的量, Ag +细胞的比例决定了ADC的功效。可以使用年龄结构模型来解决通过几个阶段的有效载荷 - 肿瘤相互作用的肿瘤抑制延迟。使用年龄结构模型来解决。旁观者杀伤效果ADC的重要主题,在几种研究中探讨了在不使用建模的情况下进行的。我们建议在考虑AG +和Ag-Celler时通过数学模型捕获旁观者杀伤效果。此外,TGI模型基础D在年龄结构上可以通过药物相互作用以及旁观者杀伤效果来捕获初始延迟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号